Chimera Peptides: A Novel Therapeutic Frontier
The innovative clinical domain is hybrid chains. These kinds of synthetic compounds combine segments from different peptide origins, enabling for distinct biological properties. This strategy offers a promising path to discover targeted medicines possessing optimized activity & minimized undesira